Heart disease prevention – what place for the glitazones?

Br J Cardiol 2006;13:66-70 Leave a comment
Click any image to enlarge
Authors:

This paper considers the role for glitazones in the treatment of type 2 diabetes following publication of the PROactive study, the first major outcome study with this class of agents. The macrovascular benefits of glitazones are discussed. Recent guidance for glitazone prescribing from the Association of British Clinical Diabetologists is also given.








Advertisement

For UK healthcare professionals only


THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT